MarketPeel
Insider Trading Intelligence
CA

Charles Albright

EDIT
EVP/CHIEF SCIENTIFIC OFFICER · EDITAS MEDICINE, INC. · CIK 0001682323
FILING MIX · LIFETIME29%/71%
BUYS
8
SELLS
20
TOTAL VALUE
$3.97M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
25,107
AVG SELL PX
$41.00
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Charles Albright, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+35.71%+9.94%+0.64%+9.30%+0.04%
14d14+42.86%+15.63%+1.08%+14.55%+4.61%
30d14+42.86%+16.67%+1.59%+15.08%+0.30%
60d14+64.29%+20.21%+1.83%+18.38%-7.04%
90d14+64.29%+9.70%+5.02%+4.68%-11.48%
180d14+35.71%+20.27%+14.62%+5.65%+7.20%
1y14+35.71%+25.58%+31.17%-5.59%-10.29%
2y14+100.00%-60.41%+21.52%-81.94%-81.43%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EDIT · 25,107 shares · as of Dec 15, 2020
048,75097,500146,250195,000SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
FLOW · 8 buys / 20 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
200$64.39$12.9K24,907Dec 15, 2020Dec 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000145,000Dec 15, 2020Dec 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
EVP/Chief Scientific Officer
10,000$16.51$165.1K34,907Dec 15, 2020Dec 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
5,776$62.74$362.4K29,131Dec 15, 2020Dec 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
4,024$63.84$256.9K25,107Dec 15, 2020Dec 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000155,000Dec 9, 2020Dec 11, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000$45.00$450.0K24,907Dec 9, 2020Dec 11, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
EVP/Chief Scientific Officer
10,000$16.51$165.1K34,907Dec 9, 2020Dec 11, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
20,000165,000Dec 7, 2020Dec 8, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
EVP/Chief Scientific Officer
20,000$16.51$330.2K44,907Dec 7, 2020Dec 8, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
20,000$40.02$800.4K24,907Dec 7, 2020Dec 8, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
228$31.21$7.1K24,907Nov 9, 2020Nov 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
3,000$31.39$94.2K25,135Oct 15, 2020Oct 16, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000$35.29$352.9K28,135Aug 17, 2020Aug 19, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000185,000Aug 17, 2020Aug 19, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
EVP/Chief Scientific Officer
10,000$16.51$165.1K38,135Aug 17, 2020Aug 19, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
238$34.99$8.3K28,135Aug 7, 2020Aug 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
EVP/Chief Scientific Officer
10,000$16.51$165.1K38,373Aug 6, 2020Aug 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000195,000Aug 6, 2020Aug 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
10,000$37.47$374.7K28,373Aug 6, 2020Aug 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
3,000$32.22$96.7K28,373Jul 15, 2020Jul 17, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
EVP/Chief Scientific Officer
151$25.28$3.8K31,373May 6, 2020May 8, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
Chief Scientific Officer
622$26.95$16.8K31,524Feb 7, 2020Feb 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
69,55669,556Feb 6, 2020Feb 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASEGRANT
Stock grant
11,59332,146Feb 6, 2020Feb 10, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
Chief Scientific Officer
5,549$26.54$147.3K20,553Feb 3, 2020Feb 4, 2020View →
EDIT
EDITAS MEDICINE, INC.
SALE
Chief Scientific Officer
17,9770Jan 31, 2020Feb 4, 2020View →
EDIT
EDITAS MEDICINE, INC.
PURCHASE
Chief Scientific Officer
17,97726,102Jan 31, 2020Feb 4, 2020View →
Other insiders · EDIT
Loading peer insiders…
About this filer
CIK 0001682323
ROLE
EVP/Chief Scientific Officer
PRIMARY
EDIT
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001682323DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback